LONDON, July 5, 2017 /PRNewswire/ -- What developments do MSL's report as changing their priorities and practice?Charting MSL Activity and Performance 2017 is a fully-updated and expanded survey of Medical Science Liaison (MSL) professionals in the US and EU5 which reveals the changing face of MSL activity and the key engagement strategies and performance metrics that are being employed today.Building on the ground breaking 2015 Survey, the new and expanded 2017 edition is now informed by the responses and experiences of 100 MSLs who work in the 100 leading pharma companies. The Survey provides analysis of the critical variations in US/European MSL activity, comparative data on how priorities and practice have changed over the last two years and where MSL's see further change in the future. For clear and actionable insights on engagement strategies, internal communications and performance measurement from frontline MSL staff, look no further than Charting MSL Activity and Performance 2017. Key Benefits:Understand which MSL activities are seen as being most important in the US and EuropeBenchmark your own MSL programmes and identify new ways to improve performanceUnderstand differing US/European attitudes in key areas such patient advocacy group interactions, MSL team creation, sales force training and KOL engagement channels, timing and performanceExamine how US/European MSLs view the value of delivering scientific presentations to KOLs and physicians and the decline of this activity in the USIdentify the most widely used measurements for evaluating MSL-KOL engagement and feedbackKnow which performance metrics are favoured for demonstrating value to internal stakeholdersUnderstand the current balance between quantitative and qualitative metrics used to measure MSL performance and gain insight as to how they may change in the futureKey Questions Answered by This Report:At what drug development stage is an MSL team established, how many brands do they handle and how does this differ between the US and Europe?How do MSL performance measurement criteria change pre to post launch?"Building new KOL relationships" is a critical post launch activity, but what outcomes are sought and how is success measured?To what extent do US and European views differ on MSL activity in supporting KOLs/physicians on patient access and patient education?What performance criteria do MSL experts see as becoming increasingly important over the near term and how has this changed in the last 2 years?In a typical month, how many KOLs/Physicians do US and EU MSLs contact and what is the most popular means of communication? Has the rise of new stakeholders changed the way MSL performance is measured?What metrics are companies using to demonstrate MSL value and how do they differ in the US and Europe?Report DeliverablesYour report purchase gives you access to unique data and analysis that can be employed practically in your plans and to hone your internal performance measurement systems:Data Report: Clear, concise and easy to read tables and charts presented as MS PowerPoint slides with expert views on key findingsData Tabulations: Full survey data provided in MS ExcelSurvey Questionnaire: delivered as a PDF documentAbout the SurveyInterview Methodology: Data collected via a 25-minute internet-based questionnaireScreening Criteria: Respondents were screened to ensure that they are MSLs or MSL managers/directorsExpanded Sample Distribution: A total of 100 US/EU5-based MSLs and MSL managers who work for pharmaceutical companies ranked in the top 100 by revenueWho will benefit from this report?MSL teams needing to ensure they are employing the latest strategies in their workMedical affairs directors needing to ensure MSL activity and training is appropriately fundedTraining professionals tasked with developing MSL skills and competenceMSL team managers executing strategy and measuring successRegulatory teams ensuring complianceMedical education professionals needing MSL feedback to develop on-target patient and physician materialsReport Content HighlightsMSL ActivitiesNumber of Brands Supported and Areas of ResponsibilityAssignment of MSLs to Brands and Discussion of New Products with PhysiciansMSL Pre-Launch and Post-Launch ActivitiesNumbers and Methods of Interactions With PhysiciansTime Spent on Proactive vs. Reactive EngagementMSL Performance MeasurementsInternal Communication Frequency and FormatPerformance Measurements Used to Evaluate MSLsMethods to Gather Information on External Value MetricsFrequency of Performance ReviewValue Demonstration to Internal Stakeholders of MSL Performance MeasurementsUsefulness of MSL Performance Measurements in Value DemonstrationExpected Changes in MSL Performance Measurements in Value DemonstrationAppendixScreeners – MSL profileDownload the full report: https://www.reportbuyer.com/product/3090979/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.comFor more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: [email protected]
Tel: +44 208 816 85 48 Website: www.reportbuyer.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/charting-msl-activity-and-performance-2017-300483711.html
SOURCE ReportBuyer
